S.Africa’s Aspen to halt Covid vaccine output as J&J orders dry up

S.Africa’s Aspen to halt Covid vaccine output as J&J orders dry up
S.Africa’s Aspen to halt Covid vaccine output as J&J orders dry up

Hello and welcome to the details of S.Africa’s Aspen to halt Covid vaccine output as J&J orders dry up and now with the details

Nevin Al Sukari - Sana'a - Demand for Johnson & Johnson vaccines has dropped in recent times. — Reuters pic

JOHANNESBURG, Aug 10 — South Africa’s Aspen Pharmacare will stop making Covid-19 vaccines from the end of this month due to a lack of orders, a senior executive said, further undermining Africa’s already meager capacity to produce doses.

Aspen currently produces vaccines for Johnson & Johnson . In March, it struck a deal to produce, price, and sell its own-brand version of the shot for African markets.

That deal was considered a game-changer for a continent frustrated by sluggish Western handouts. But, while only a fifth of adults in Africa are fully vaccinated, according to the African Centres for Disease Control and Prevention, demand for shots have failed to materialise.

Aspen has had no orders for its Aspenovax vaccine and has not received orders from Johnson & Johnson beyond August.

J&J did not respond to an email seeking comment.

“The thing here is that we don’t know if we will get further orders from J&J. But we are finishing off production of what we’ve got,” Stavros Nicolaou, group senior executive at Aspen, told Reuters.

Without new orders, Aspen would have to shut down all of its 450 million-dose annual production capacity, he said.

Aspen could get some indication from J&J by September as to whether any new orders are in the pipeline, Nicolaou said. But he cautioned that those might not be enough.

The bulk of the company’s Covid-19 production lines had been meant to produce Aspenovax for Africa. Its initial plans aimed to boost annual capacity to 700 million doses by February and a further expansion to one billion doses to meet expected demand.

However, its existing Aspenovax production lines are currently sitting idle. Without Aspenovax orders, Aspen would be forced to convert production lines to manufacture anaesthetics, Nicolaou said.

“Then Africa loses its Covid vaccine capacity, the only one really that exists on the continent,” he said. “Of course we cannot continue with vacant lines indefinitely. And we would have to get an order imminently.” — Reuters

These were the details of the news S.Africa’s Aspen to halt Covid vaccine output as J&J orders dry up for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT Barrage of Russian attacks aims to cut Ukraine's lights

Author Information

I am Jeff King and I’m passionate about business and finance news with over 4 years in the industry starting as a writer working my way up into senior positions. I am the driving force behind Al-KhaleejToday.NET with a vision to broaden the company’s readership throughout 2016. I am an editor and reporter of “Financial” category. Address: 383 576 Gladwell Street Longview, TX 75604, USA Phone: (+1) 903-247-0907 Email: [email protected]